ID
45935
Beschrijving
Principal Investigator: Michael B Cook, PhD, National Cancer Institute, NIH, Rockville, MD, USA MeSH: Prostatic Neoplasms,Prostatic Hyperplasia https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000838 Participants were recruited through the Ghana Prostate Study-a population-based component, and a clinical component. The population-based component was a probability sample designed using the 2000 Ghana Population and Housing Census data in an attempt to recruit approximately 1,000 men aged 50-74 years in the Greater Accra region (~3 million people), which successfully recruited 1,037 healthy men between 2004 and 2006 with a response percentage of 98.8 %. Consented individuals underwent an in-person interview, and within 7 days had a digital rectal examination (DRE) and provided an overnight fasting blood sample for prostate-specific antigen (PSA) testing, biomarker assays, and genetic analysis. Subjects who had a positive screen by PSA (2.5 ng/ml) or DRE underwent a transrectal ultrasound-guided biopsy. A total of 73 histologically confirmed prostate cancer cases were identified through the population-based screening component of the Ghana Prostate Study and were included in the case population in the published GWAS (Cook et al., Human genetics, 2013). From the remaining 964 screen-negative individuals, 836 had at least 20 μg DNA extracted and available for analysis, and 500 of these were matched to cases for analysis by age (in 5-year categories). In the Ghana Prostate Study, we recruited 676 prostate cancer cases at Korle Bu Teaching Hospital in Accra, Ghana, between 2008 and 2012. All consented cases were interviewed and provided an overnight fasting blood sample. At the time of selection for this analysis we had recruited 582 prostate cancer cases, from which we selected 427 for analysis. Combined with the 73 cases diagnosed through the population-based component of the study, this yielded 500 available prostate cancer cases for analysis.
Link
Trefwoorden
Versies (1)
- 09-03-24 09-03-24 - Madita Rudolph
Houder van rechten
Michael B Cook, PhD, National Cancer Institute, NIH, Rockville, MD, USA
Geüploaded op
9 maart 2024
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000838 Ghana Prostate Study
Subject ID, consent group, and affection status of participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
- Subject ID, affection status, gender, age, Gleason Score, and population structure principal component participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
- Sample ID, histological type, body site, analyte type, and tumor status of participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
Similar models
Subject ID, consent group, and affection status of participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, consent group, and affection status of participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
- Subject ID, sample ID, and sample use variable obtained from participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
- Subject ID, affection status, gender, age, Gleason Score, and population structure principal component participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
- Sample ID, histological type, body site, analyte type, and tumor status of participants with or without prostate cancer and involved in the "Ghana Prostate Study" project.
C2348585 (UMLS CUI [1,2])
Geen commentaren